Parth Modi to Prostatic Neoplasms
This is a "connection" page, showing publications Parth Modi has written about Prostatic Neoplasms.
Connection Strength
4.080
-
Characteristics of prostate cancer patients captured by facility-based versus geography-based cancer registries. Urol Oncol. 2023 07; 41(7):324.e1-324.e7.
Score: 0.393
-
Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees. Urology. 2021 09; 155:77-82.
Score: 0.337
-
Prostate-specific Antigen to Predict Early Success of Focal Therapy: Focusing on Appropriate Endpoints. Eur Urol. 2020 08; 78(2):161-162.
Score: 0.322
-
Practice-Level Adoption of Conservative Management for Prostate Cancer. J Oncol Pract. 2019 10; 15(10):e863-e869.
Score: 0.305
-
Urologist Practice Structure and Spending for Prostate Cancer Care. Urology. 2019 Aug; 130:65-71.
Score: 0.297
-
EDITORIAL COMMENT. Urology. 2019 02; 124:105-106.
Score: 0.292
-
Searching for the value of accountable care organizations in cancer care. Cancer. 2018 11 15; 124(22):4287-4289.
Score: 0.288
-
National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms. Urology. 2018 Oct; 120:96-102.
Score: 0.281
-
Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations. Cancer. 2018 08; 124(16):3364-3371.
Score: 0.280
-
Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy. Clin Genitourin Cancer. 2017 12; 15(6):e1001-e1006.
Score: 0.259
-
Safety of Robot-Assisted Radical Prostatectomy with Pneumoperitoneum of 20?mm Hg: A Study of 751 Patients. J Endourol. 2015 Oct; 29(10):1148-51.
Score: 0.228
-
Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case Series. Urology. 2022 09; 167:171-178.
Score: 0.091
-
Testing-Related Health Impact of Transrectal and Transperineal Prostate Biopsy as Assessed by Health Utilities. J Urol. 2021 12; 206(6):1403-1410.
Score: 0.087
-
Adherence and out-of-pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer. Cancer. 2020 12 01; 126(23):5050-5059.
Score: 0.082
-
Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation. Cancer. 2020 12 01; 126(23):5114-5123.
Score: 0.082
-
Tradeoffs in Refining the Diagnosis of Prostate Cancer. Eur Urol. 2018 12; 74(6):729-730.
Score: 0.070
-
Intracrine androgen biosynthesis in renal cell carcinoma. Br J Cancer. 2017 Mar 28; 116(7):937-943.
Score: 0.064
-
Long-Term Outcomes of Using Hyaluronic Acid-Carboxymethylcellulose Adhesion Barrier Film on the Neurovascular Bundle. J Endourol. 2016 06; 30(6):709-13.
Score: 0.061
-
Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer. Clin Genitourin Cancer. 2016 Feb; 14(1):e1-8.
Score: 0.057
-
Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study. BMC Urol. 2015 Aug 01; 15:79.
Score: 0.057
-
Regional Cost Variations of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy. Clin Genitourin Cancer. 2015 Oct; 13(5):447-52.
Score: 0.057
-
Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study. J Urol. 2013 Aug; 190(2):527-34.
Score: 0.048
-
Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination. Prostate. 2011 Mar 01; 71(4):394-402.
Score: 0.041